Alessandro Re

15PUBLICATIONS
152CO-AUTHORS
Haematological tumoursPredictive and prognostic markersAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 04, 2026
Role of direct-acting antivirals in people with HIV-associated non-Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi.

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Feb 27, 2026
Autologous Stem Cell Transplantation in HIV-Positive and HIV-Negative Patients with Lymphoma: A Propensity Score-Matched Comparative Analysis.

Alessandro Re, Margherita Oberti, Armando Stabile

|Dec 30, 2025
Secondary Genetic Events and Their Relationship to TP53 Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL).

Maria Elena Carazzolo, Francesca Maria Quaglia, Antonino Aparo

|Dec 29, 2025
Brentuximab vedotin and nivolumab in combination with chemotherapy for nonbulky, early-stage classical Hodgkin lymphoma.

Jeremy S Abramson, David J Straus, Nancy L Bartlett

|Mar 08, 2025
A phase 2 study of autologous stem cell transplantation as salvage therapy for older patients with aggressive B-cell lymphoma prospectively evaluated by comprehensive geriatric assessment: the FIL_RECANZ study.

Alessandra Tucci, Alessandro Re, Chiara Pagani

Pageof 3

Frequent Collaborators

5 joint publications

Alessandra Tucci

5 joint publications

Carlo Visco

5 joint publications

Vittorio Ruggero Zilioli

4 joint publications

Chiara Cattaneo